Clinical trial
Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of…
NCT00010088 · GERCOR - Multidisciplinary Oncology Cooperative Group, Other · Unknown status
Key facts
| NCT number | NCT00010088 |
|---|---|
| Title | Chemotherapy in Treating Patients With Locally Advanced or Metastatic Cancer of the Pancreas or Bile Duct |
| Official title | Study Of Gemcitabine, Leukovorin, And Fluorouracil Used To Treat Locally Advanced And Metastatic Pancreatic And Biliary Adenocarcinomas |
| Lead sponsor | GERCOR - Multidisciplinary Oncology Cooperative Group, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Extrahepatic Bile Duct Cancer, Pancreatic Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | fluorouracil, gemcitabine hydrochloride, leucovorin calcium, conventional surgery, radiation therapy |
| Start date | Jan 1, 1999 |
| First posted | May 20, 2004 |
| Last update posted | Feb 9, 2009 |
| Countries | France, Luxembourg |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: